Medtronic (MDT) Income from Non-Controlling Interests (2016 - 2026)
Medtronic (MDT) reported Income from Non-Controlling Interests of $16.0 million for Q2 2026, up 220.0% on a YoY basis from $5.0 million in Q2 2025, and up 166.67% sequentially from $6.0 million in Q1 2026.
Medtronic (MDT) Income from Non-Controlling Interests (2016 - 2026) Analysis & Trends
Medtronic (MDT) has 11 years of Income from Non-Controlling Interests data on file, last reported at $16.0 million in Q2 2026.
- For the quarter ending Q2 2026, Income from Non-Controlling Interests rose 220.0% year-over-year to $16.0 million; the trailing twelve-month figure through Apr 2026 stood at $36.0 million (up 24.14% YoY), and the FY2026 full-year result was $37.0 million, up 27.59% from the prior year.
- Income from Non-Controlling Interests rose to $16.0 million in Q2 2026, from $6.0 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $16.0 million in Q2 2026 to a low of $2.0 million in Q3 2022.
- A 5-year average of $7.1 million and a median of $6.0 million in 2022 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests slumped 75.0% in 2023 and surged 350.0% in 2024, its largest moves.
- Tracing MDT's Income from Non-Controlling Interests over 5 years: stood at $8.0 million in 2022, then tumbled by 75.0% to $2.0 million in 2023, then surged by 350.0% to $9.0 million in 2024, then declined by 22.22% to $7.0 million in 2025, then soared by 128.57% to $16.0 million in 2026.
- Business Quant data shows MDT's Income from Non-Controlling Interests at $16.0 million in Q2 2026, $6.0 million in Q1 2026, and $7.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 16.00 Mn |
| Jan 23, 2026 | 6.00 Mn |
| Oct 24, 2025 | 7.00 Mn |
| Jul 25, 2025 | 7.00 Mn |
| Apr 25, 2025 | 5.00 Mn |
| Jan 24, 2025 | 9.00 Mn |
| Oct 25, 2024 | 9.00 Mn |
| Jul 26, 2024 | 6.00 Mn |
| Apr 26, 2024 | 5.00 Mn |
| Jan 26, 2024 | 15.00 Mn |
| Oct 27, 2023 | 2.00 Mn |
| Jul 28, 2023 | 6.00 Mn |
| Apr 28, 2023 | 9.00 Mn |
| Jan 27, 2023 | 6.00 Mn |
| Oct 28, 2022 | 8.00 Mn |
| Jul 29, 2022 | 2.00 Mn |
| Apr 29, 2022 | 6.00 Mn |
| Jan 28, 2022 | 4.00 Mn |
| Oct 29, 2021 | 6.00 Mn |
| Jul 30, 2021 | 6.00 Mn |